Compare Becton Dickinson and Co (BDX) vs Eos Energy Enterprises Inc (EOSE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Eos Energy Enterprises Inc — how do they compare? Becton Dickinson and Co trades at $156.25 (market cap $41.51B), while Eos Energy Enterprises Inc trades at $4.46 (market cap $1.52B). The key difference: Becton Dickinson and Co is far larger — about 27.3× Eos Energy Enterprises Inc's market cap, and Becton Dickinson and Co pays a 2.79% dividend while Eos Energy Enterprises Inc pays none. Which is the better fit depends on your goals.
| BDX | EOSE | |
|---|---|---|
Market Cap | $41.51B | $1.52B |
Sector | Health | Energy |
52-Week High | $185.39 | $19.19 |
52-Week Low | $135.49 | $4.29 |
Enterprise Value | $57.97B | $1.75B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Eos Energy Enterprises (EOSE) trades at $4.35, down 1.14% on the day, amid a bearish technical trend and challenging fundamentals. The company reported a net loss of $969.65 million on $114.20 million in revenue for 2025, with negative gross and net profit margins. However, recent news highlights project wins, including a 400 MWh battery storage selection, and a $125 million investment for its Frontier Power USA platform, signaling growth potential in the long-duration energy storage market.
The outlook is a balance of high execution risk against significant growth opportunity. While analyst consensus is a 'Hold' with a $8.40 price target, the company's path to profitability remains uncertain. Key risks include persistent cash burn and high debt-to-asset ratio, but successful commercialization of its zinc-based battery technology could drive substantial upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →
